Journal Clubs
A home for scientific conversation.
Invite a paper's author to join your next session.
Latest journal club recapJun 26, 2026
ORBITA-CTO: The Heart of the Matter
The ORBITA-CTO trial represents a significant advancement in the understanding of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) for relieving angina. By employing a rigorous randomized, double-blind, placebo-controlled design, the study successfully differentiated between the placebo effect and the true therapeutic benefits of CTO PCI, showing it leads to marked improvements in angina symptom reduction over a 24-week follow-up period.
Key takeaway: The trial demonstrated that CTO PCI improves angina symptoms beyond placebo, particularly reducing angina frequency.
30:34
With David J. Cohen and 13 experts
Find your room
Discover clubs
Continue the conversation
Your clubs
The new home
for science
Where leading experts discuss new research and decide what matters.
Explore Journal Clubs